Cormorant Asset Management’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
Cormorant Asset Management's ATTO Position: Q3 2026 in Review
Cormorant Asset Management opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,788,815 shares worth $30.7M. The stake represents 2.06% of the portfolio and ranks #15 among its holdings.
57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- Cormorant Asset Management held 1,788,815 shares of Attovia Therapeutics worth $30.7M as of Q3 2026.
- Attovia Therapeutics was a new Cormorant Asset Management position in Q3 2026.
- Attovia Therapeutics made up 2.06% of Cormorant Asset Management's portfolio in Q3 2026, its #15 holding.
- 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.